Keystonemab
The AI engine Fit Assessment
BetaKeystonemab leverages machine learning to discover complex patterns and expand therapeutic uses of existing drugs, including drug repurposing strategies.
Blurb
Developer of scientific analytics platform designed to derive key insights from vast amounts of data to make smart project-related decisions.
HQ Location
Netherlands
Founded
2019
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Developer of scientific analytics platform designed to derive key insights from vast amounts of data to make smart project-related decisions. The company's platform leverages real-time scientific information from millions of scientific, clinical, and patent documents using AI to accelerate, enabling users the translate knowledge from actionable insights of publications.